MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Cognitive assessment of Parkinson’s disease carriers of the novel p.A30G mutation in the SNCA gene

    C. Koros, I. Alefanti, AM. Simitsi, A. Bougea, N. Papagiannakis, R. Antonelou, C. Kartanou, M. Bozi, I. Pachi, S. Varvaresos, A. Zahou, E. Stanitsa, M. Kodounis, M. Maniati, M. Panas, G. Paraskevas, S. Papageorgiou, C. Potagas, G. Karadima, G. Koutsis, L. Stefanis (Athens, Greece)

    Objective: The aim of the present report was to evaluate the cognitive profile of symptomatic Parkinson’s disease (PD) patients in a p.A30G SNCA genetic cohort.…
  • 2023 International Congress

    Impact of the COVID-19 pandemic in the long-term efficacy of botulinum toxin treatment

    F. Barros, C. Nunes, F. Magalhães, A. Mestre, C. Machado, D. Carneiro (Coimbra, Portugal)

    Objective: To analyse the impact of the COVID-19 pandemic in the long-term efficacy of treatment with botulinum toxin (BoT). Background: The COVID-19 pandemic brought new…
  • 2023 International Congress

    Exploring the complementary approach of a standardized osteopathic treatment protocol on sleep quality in Parkinsons disease: A randomized controlled study

    S. Yao, J. Difrancisco-Donoghue, A. Leder, J. Mancini, J. Docherty (Old Westbury, USA)

    Objective: To investigate the complementary effects of a standardized Osteopathic Manipulative Treatment (OMT) Protocol on sleep quality using the Pittsburgh Sleep Index (PSQI) Background: Parkinson’s…
  • 2023 International Congress

    Obsessive-Compulsive symptoms in Parkinson’s Disease: beyond the Impulse Control Disorders

    D. Damas, M. Fernandes, I. Carvalho, C. Fernandes, A. Araújo, I. Cunha, J. Lemos, F. Moreira (Coimbra, Portugal)

    Objective: To characterize the obsessive-compulsive symptoms (OCS) and Impulse Control Disorders (ICD) in patients with Parkinson’s Disease (PD), as well as explore the correlation between…
  • 2023 International Congress

    Pain and sleep in Parkinson’s disease

    A. Zarnoveanu, S. Diaconu, B. Ciopleias, L. Ungureanu, T. Dragan, B. Ciocanescu, T. Moldovan, C. Falup-Pecurariu (Brasov, Romania)

    Objective: Pain and sleep disturbances are among the most frequently encountered non-motor symptoms in Parkinson’s disease (PD). Background: The aim of this study was to…
  • 2023 International Congress

    Relationship between the Montreal Cognitive Assessment and clinical gait assessments in individuals with Parkinson disease

    A. Boddy, K. Barta, L. Perry, M. Flores, K. Sawyer, A. Campbell (St Augustine, USA)

    Objective: Determine the relationship between the Montreal Cognitive Assessment (MoCA) and the commonly used clinical gait assessments including 10-meter walk test (10 MWT), 4-meter walk…
  • 2023 International Congress

    Gluten-free diet in Parkinson’s disease patients – feasibility, safety and preliminary results

    H. Brozova, K. Polakova, M. Fialova, T. Gentileova, J. Rusz, D. Funda (Prague, Czech Republic)

    Objective: The primary objective of this project is to evaluate the effect of long administered gluten-free diet (GFD) on motor symptoms of Parkinson's disease (PD).…
  • 2023 International Congress

    Ultrasound-guided selective diagnostic nerve block in patients with elbow spasticity: a retrospective pilot study.

    E. Bianchini, A. Massimiani, J. Bemporad, M. Giovannelli (Rome, Italy)

    Objective: To evaluate efficacy and patients’ perception of the ultrasound-guided selective diagnostic nerve block (DNB) of the motor branch for brachialis muscle compared with the…
  • 2023 International Congress

    Safety and performance of DBS primary cell IPG replacement: An interim report from the ADROIT study

    S. Groppa, J. Muñoz, K. Ashkan, A. Gharabaghi, T. Tomlinson, M. Frassica, M. Navas Garcia (Mainz, Germany)

    Objective: To present procedure-related safety of DBS IPG battery replacements and variations of therapeutic performance within the ADROIT post-market study. Background: DBS implantable pulse generator…
  • 2023 International Congress

    Cognitive Interference in Postural Control as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders.

    R. Lloyd, C. Fearon, R. Reilly (Dublin, Ireland)

    Objective: The purpose of this research is to explore whether Progressive supranuclear palsy (PSP) patients display distinct sway patterns compared to idiopathic Parkinson's disease (PD)…
  • « Previous Page
  • 1
  • …
  • 171
  • 172
  • 173
  • 174
  • 175
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley